Upload Avatar (500 x 500)
田君
Medical School
南方科技大学
广东省
Language: 英语, 汉语
癌症
靶向治疗
免疫治疗
药物耐药
机制
肿瘤
器官模型
药物测试
肿瘤学
治疗策略
Areas of Focus
- 癌症的靶向和免疫治疗
- 药物耐药性机制
- 肿瘤类器官模型的建立和药物测试
Work Experience
- 2023.08-至今 南方科技大学医学院，助理教授
- 2019-2023 美国哈佛医学院麻省总医院，博士后
- 2018-2019 加拿大麦吉尔大学健康中心，博士后
Academic Background & Achievements
- 2009-2013 学士: 南开大学
- 2013-2018 博士: 加拿大麦吉尔大学
- 获得麦吉尔大学优秀博士毕业生奖
Publications
- Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial, 田君等, 2023
- Targeting TBK1 to overcome resistance to cancer immunotherapy, 田君等, 2023
- Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition, 田君等, 2021
- Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis, 田君等, 2021
- Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells, 田君等, 2018
- KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer, 田君等, 2018
- Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer, 田君等, 2017
- Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function, 田君等, 2017
- The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma, 田君等, 2015
- Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes, 田君等, 2014
Awards
- 2018: 加拿大麦吉尔大学优秀博士毕业生奖
- 2017: 加拿大麦吉尔大学医学院优秀生产力奖
